MedTrace Logo

Non Exudative AMD Imaged With SS-OCT

NCT03688243 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 225

Last updated 2022-03-10

No results posted yet for this study

Summary

The investigators wish to better understand the role of the choriocapillaris (CC) in the formation and progression of non-exudative in age related macular degeneration (armd) by imaging the retinal pigment epithelium (rpe) and the choroidal microvasculature and by studying their inter-dependence to determine if the loss of the CC could prove useful as an anatomic clinical trial endpoint in future drug trials.

Conditions

  • Dry Macular Degeneration

Interventions

DEVICE

SS-OCT imaging

All subjects will undergo retinal imaging using the Zeiss PlexElite SS-OCT, a non-contact, non-invasive ocular imaging instrument

Sponsors & Collaborators

  • Boston Image Reading Center

    lead INDUSTRY

Principal Investigators

  • Nadia Waheed, MD · Boston Image Reading Center/Tufts Medical Center

  • Philip Rosenfield, MD, PhD · Bascom Palmer Eye Institute

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-18
Primary Completion
2023-03-31
Completion
2023-03-31
FDA Device
Yes

Countries

  • United States
  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03688243 on ClinicalTrials.gov